These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21329552)

  • 1. Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents?
    Karanges E; Li KM; Motbey C; Callaghan PD; Katsifis A; McGregor IS
    Int J Neuropsychopharmacol; 2011 May; 14(4):491-504. PubMed ID: 21329552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
    PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
    Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
    Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting regional Fos expression in adolescent and young adult rats following acute administration of the antidepressant paroxetine.
    Karanges EA; Ramos L; Dampney B; Suraev AS; Li KM; McGregor IS; Hunt GE
    Brain Res Bull; 2016 Mar; 121():246-54. PubMed ID: 26876759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
    Leggio GM; Micale V; Drago F
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action.
    Dutta AK; Ghosh B; Biswas S; Reith ME
    Eur J Pharmacol; 2008 Jul; 589(1-3):73-9. PubMed ID: 18561912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats.
    Takahashi T; Morinobu S; Iwamoto Y; Yamawaki S
    Psychopharmacology (Berl); 2006 Dec; 189(2):165-73. PubMed ID: 17031709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
    Oosting RS; Chan JS; Olivier B; Banerjee P; Choi YK; Tarazi F
    Psychopharmacology (Berl); 2016 Mar; 233(6):1025-34. PubMed ID: 26758283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.
    Gould GG; Pardon MC; Morilak DA; Frazer A
    Neuropsychopharmacology; 2003 Sep; 28(9):1633-41. PubMed ID: 12825093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA, glutamate, dopamine and serotonin transporters expression on forgetting.
    Tellez R; Gómez-Viquez L; Liy-Salmeron G; Meneses A
    Neurobiol Learn Mem; 2012 Jul; 98(1):66-77. PubMed ID: 22633984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM; Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Dell'isola R; Katzman AC; Bishop C
    Neuropharmacology; 2014 Feb; 77():1-8. PubMed ID: 24067924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.